Gilead Sciences (GILD) EPS (Basic) (2009 - 2026)
Gilead Sciences' (GILD) quarterly EPS (Basic) came in at $1.63 in Q1 2026, up 54.18% YoY from $1.06 in Q1 2025, and down 19.93% on a QoQ basis from $2.03 in Q4 2025.
Gilead Sciences (GILD) EPS (Basic) (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 18 years of EPS (Basic) data on file, last reported at $1.63 in Q1 2026.
- Quarterly EPS (Basic) rose 54.18% year-over-year to $1.63 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.7 (up 60.82% YoY) and the FY2025 annual result came in at $6.84, up 1680.9% from the prior year.
- EPS (Basic) retreated to $1.63 in Q1 2026, from $2.03 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $2.46 in Q3 2025 to a low of -$3.34 in Q1 2024.
- A 5-year average of $1.02 and a median of $1.3 in 2024 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) jumped 8145.99% — and 2024, when it sank 524.22%.
- Tracing GILD's EPS (Basic) over 5 years: stood at $1.3 in 2022, then fell by 12.8% to $1.13 in 2023, then climbed by 25.95% to $1.43 in 2024, then jumped by 42.21% to $2.03 in 2025, then retreated by 19.93% to $1.63 in 2026.
- The last three EPS (Basic) figures came in at $1.63 (Q1 2026), $2.03 (Q4 2025), and $2.46 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 463.46 Bn | 456.89 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.92 Bn | 360.78 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 297.71 Bn | 290.02 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 255.55 Bn | 250.65 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 234.52 Bn | 220.53 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 178.22 Bn | 175.04 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.32 Bn | 101.15 Bn | 8.24 Bn | 0.29 |
| 10 | Sanofi | 54.20 Bn | 46.82 Bn | 10.79 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.44 |
| Mar 31, 2026 | 1.63 |
| Dec 31, 2025 | 2.03 |
| Sep 30, 2025 | 2.46 |
| Jun 30, 2025 | 1.58 |
| Mar 31, 2025 | 1.06 |
| Dec 31, 2024 | 1.43 |
| Sep 30, 2024 | 1.00 |
| Jun 30, 2024 | 1.30 |
| Mar 31, 2024 | -3.34 |
| Dec 31, 2023 | 1.13 |
| Sep 30, 2023 | 1.74 |
| Jun 30, 2023 | 0.83 |
| Mar 31, 2023 | 0.79 |
| Dec 31, 2022 | 1.30 |
| Sep 30, 2022 | 1.42 |
| Jun 30, 2022 | 0.90 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.30 |
| Sep 30, 2021 | 2.06 |